Intracranial hemorrhage secondary to uncontrolled hypertension - Nursing Case Study

Pathophysiology

• Primary mechanism: Uncontrolled hypertension causes chronic damage to small blood vessels in the brain, leading to arteriosclerosis. This thickening and hardening of the vessel walls reduce their elasticity and make them prone to rupture under persistent high pressure.

• Secondary mechanism: Hypertension-induced damage can also result in microaneurysm formation, particularly in small penetrating arteries. These microaneurysms are weak spots that are susceptible to bursting, causing localized bleeding within the brain tissue.

• Key complication: Rupture of these weakened vessels or microaneurysms leads to intracranial hemorrhage, which increases intracranial pressure, potentially causing mass effect and brain herniation, posing significant risk for neurological deficits or death.

Patient Profile

Demographics:

55-year-old male, construction worker

History:

• Key past medical history: Uncontrolled hypertension for 10 years, history of smoking, hyperlipidemia

• Current medications: Lisinopril 20 mg once daily, Atorvastatin 40 mg once daily, occasional use of over-the-counter NSAIDs

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe headache and confusion

• Key symptoms: Nausea, vomiting, weakness on the right side of the body, slurred speech

• Vital signs: Blood pressure 210/120 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 93% on room air

Section 1

As the healthcare team conducts the initial assessment, they note the patient's Glasgow Coma Scale (GCS) score has decreased to 10, indicating a moderate level of impaired consciousness. The patient exhibits significant weakness on the right side, confirmed by a motor strength assessment showing 2/5 strength in the right arm and leg, while the left side remains at a normal 5/5. Pupillary response is unequal, with the left pupil being sluggish to react compared to the right, suggesting possible increased intracranial pressure affecting the brainstem. The patient's blood pressure remains critically elevated at 215/118 mmHg despite initial attempts to manage it with increased doses of Lisinopril and the introduction of a nicardipine infusion to provide rapid antihypertensive effects.

Further diagnostic imaging, including a CT scan of the brain, reveals a significant hemorrhage in the left basal ganglia region with a midline shift, indicating mass effect. The radiologist notes the presence of surrounding edema, which is contributing to the increased intracranial pressure. Laboratory results indicate a slight elevation in white blood cell count, suggesting a stress response, but no signs of infection. Serum electrolytes are within normal limits, but renal function tests show an elevated creatinine level, possibly due to hypertensive nephropathy exacerbated by NSAID use.

The healthcare team must now decide on the next course of action, weighing the risks of aggressive blood pressure management against the potential for reduced cerebral perfusion pressure. Neurosurgical consultation is requested to evaluate the possibility of surgical intervention to relieve the pressure and prevent further neurological deterioration. This decision-making process requires careful consideration of the patient's overall stability, existing comorbidities, and the potential for recovery versus risk of further complications.

Section 2

As the healthcare team continues to monitor the patient, a sudden change in status is observed. The patient's GCS score decreases further to 8, indicating severe impairment of consciousness. This development is accompanied by a noticeable increase in the patient's respiratory rate to 28 breaths per minute, with shallow breathing patterns suggesting potential respiratory compromise due to brainstem involvement. Blood pressure remains critically elevated at 210/115 mmHg despite ongoing treatment efforts with nicardipine, raising concerns about the adequacy of cerebral perfusion pressure and further neurological decline.

The neurosurgical team arrives to assess the situation and highlights the urgency of the case. They recommend immediate surgical intervention to evacuate the hematoma and relieve the midline shift, as the risk of herniation is increasing. Meanwhile, the nursing team prepares the patient for surgery, ensuring all pre-operative protocols are followed. Continuous monitoring of vital signs reveals a further drop in heart rate to 48 beats per minute, indicating possible Cushing's triad, a sign of escalating intracranial pressure. This necessitates urgent action to prevent catastrophic outcomes.

In light of these developments, the healthcare team revisits the patient's medication regimen, considering the potential need for additional agents such as mannitol or hypertonic saline to manage cerebral edema pre-operatively. The interdisciplinary team discusses the balance between aggressive blood pressure management and maintaining adequate cerebral perfusion. The decision is made to proceed with surgery, with the understanding that the patient's renal function will require close monitoring post-operatively due to the potential impact of surgical and medication interventions on kidney health. The team remains vigilant, aware that the patient's journey will require ongoing adjustments and careful management to navigate the complex interplay of complications associated with uncontrolled hypertension and intracranial hemorrhage.

Section 3

As the patient is wheeled into surgery, the healthcare team reflects on the immediate pre-operative phase, carefully considering the balance between managing intracranial pressure and maintaining cerebral perfusion. Despite the administration of nicardipine, blood pressure remains perilously high, prompting the team to introduce mannitol as an osmotic diuretic to reduce cerebral edema. The nursing staff administers 0.5 g/kg of mannitol intravenously, monitoring for any diuresis and shifts in electrolyte balance, which could potentially complicate the patient's renal status. Concurrently, the neurosurgical team prepares for a craniotomy, aiming to evacuate the hematoma and address the midline shift that threatens to progress to brain herniation.

The surgical intervention proceeds with urgency, and as the hematoma is evacuated, there is a cautious optimism in the operating room. Post-operatively, the patient is transferred to the intensive care unit for continuous monitoring. Initial post-operative assessments reveal a slight improvement in the Glasgow Coma Scale score, now at 10, indicating some recovery of consciousness. However, the patient's blood pressure remains a critical concern, with fluctuations between 180/100 mmHg and 200/110 mmHg. The team decides to continue the nicardipine infusion at a lower rate, supplemented by titrated doses of labetalol to achieve a more stable hemodynamic profile without compromising cerebral perfusion.

The interdisciplinary team remains vigilant for signs of new complications, particularly focusing on renal function given the potential nephrotoxicity of mannitol and the extensive surgical intervention. Initial laboratory results show a slight increase in serum creatinine from 1.0 mg/dL to 1.3 mg/dL, prompting the nephrology consult to weigh in on fluid management and renal protective strategies. The patient’s respiratory status is closely monitored as well, given the prior signs of brainstem involvement. The healthcare team collaborates to adjust ventilatory support, ensuring adequate oxygenation while avoiding excessive hyperventilation that could further lower intracranial pressure. With these interventions, the patient enters a critical phase of recovery, where each clinical decision is pivotal in navigating the complexities of intracranial hemorrhage secondary to uncontrolled hypertension.

Section 4

As the patient settles into the critical care environment, the interdisciplinary team maintains a vigilant watch for any changes in status that could indicate new or worsening complications. Over the next few hours, the patient exhibits a gradual decrease in urine output, dropping from an initial 50 mL/hour to 20 mL/hour. This prompts immediate concern regarding potential acute kidney injury, potentially exacerbated by the osmotic diuresis from the mannitol administration. Further laboratory tests reveal an increase in serum creatinine to 1.6 mg/dL and a rise in blood urea nitrogen (BUN) from 18 mg/dL to 28 mg/dL, suggesting impaired renal function. The nephrology team recommends a cautious approach to fluid management, emphasizing the importance of maintaining adequate hydration while avoiding fluid overload, which could aggravate cerebral edema.

Concurrently, the patient's neurological status shows subtle but concerning changes. Despite the earlier improvement in the Glasgow Coma Scale score, the patient now demonstrates slight right-sided weakness and a sluggish pupillary response on the left side. These findings raise the possibility of recurrent or expanding cerebral edema or a new hemorrhagic event. The neurosurgical team orders an urgent CT scan to evaluate for any changes in intracranial structures. The imaging reveals a small, new area of bleeding near the original hematoma site, albeit without significant midline shift or signs of herniation at this time.

In response to these developments, the healthcare team recalibrates its strategy. The nicardipine infusion is adjusted further to maintain blood pressure within a target range of 160-180/90-100 mmHg, balancing the dual objectives of reducing the risk of additional bleeding while ensuring sufficient cerebral perfusion. Meanwhile, the labetalol doses are carefully titrated to achieve steady hemodynamic control. The nursing staff increases the frequency of neurological assessments and closely monitors renal function, ready to implement additional interventions should the patient's condition evolve. This meticulous, coordinated effort underscores the complexity of managing intracranial hemorrhage in the context of uncontrolled hypertension, as each decision holds the potential to impact the patient's recovery trajectory significantly.

Section 5

As the patient's care continues, new diagnostic results emerge that provide further insights into the evolving clinical picture. The urgent CT scan performed earlier indicates a small, new area of bleeding near the original hematoma site. While there is no significant midline shift or signs of herniation, the presence of additional bleeding necessitates close monitoring and reassessment of the treatment approach. The neurosurgical team decides against immediate surgical intervention, opting instead for a conservative management strategy, given the current stability of the patient's neurological status.

Simultaneously, repeat laboratory tests show a further increase in serum creatinine to 1.9 mg/dL, and BUN has risen to 32 mg/dL, confirming a trend toward acute kidney injury. Additional electrolyte panels reveal a mild hyponatremia with a sodium level of 132 mEq/L, which could contribute to neurological symptoms and requires careful correction. The nephrology team emphasizes the need to adjust the fluid management plan, prioritizing isotonic fluids to address the hyponatremia while continuing to monitor for signs of fluid overload.

The interdisciplinary team convenes to discuss these findings and recalibrate the management plan. Given the dual challenges of intracranial pressure management and renal function preservation, they decide to decrease the dosage of mannitol to mitigate its osmotic diuretic effects, which could exacerbate renal compromise. Attention shifts to optimizing antihypertensive therapy to prevent further cerebral bleeding. The team also reinforces the importance of frequent neurological assessments to detect any subtle changes that might necessitate a more aggressive intervention. This stage of the patient's journey underscores the delicate balance required in managing complex, interrelated complications, highlighting the importance of ongoing assessment and timely adjustments to the care plan.